Open AccessASH Registry Offers Insights on COVID ‐19 in Patients with Hematologic Malignancies
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13657
Subject(s) - medicine , covid-19 , hematology , hematologic neoplasms , intensive care medicine , emergency medicine , cancer , virology , outbreak , disease , infectious disease (medical specialty)
For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.